作者：
Maike,Trommer [1]
;
Jaika,Kinsky [2]
;
Anne,Adams [3]
;
Martin,Hellmich [4]
;
Max,Schlaak [1]
;
Michael,von Bergwelt-Baildon [5]
;
Eren,Celik [5]
;
Johannes,Rosenbrock [2]
;
Janis,Morgenthaler [6]
;
Jan M,Herter [2]
;
Philipp,Linde [7]
;
Cornelia,Mauch [1]
;
Sebastian,Theurich [3]
;
Simone,Marnitz [1]
;
Christian,Baues [3]
作者单位：
Department of Radiation Oncology and Cyberknife Center, University Hospital of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
[1]
Radio Immune-Oncology Consortium (RIO), University Hospital of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
[2]
Center for Integrated Oncology (CIO), University Hospital of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
[3]
Center for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
[4]
Institute of Medical Statistics and Computational Biology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
[5]
Department of Dermatology and Allergology, LMU University Hospital, Ludwig-Maximilians University (LMU), Munich, Frauenlobstr. 9-11, 80377 Munich, Germany.
[6]
Department III of Internal Medicine, LMU University Hospital, Ludwig-Maximilians University (LMU), Munich, Marchioninistr. 15, 81377 Munich, Germany.
[7]
Department of Dermatology and Allergology, University Hospital of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
[8]
Cancer & Immunometabolism Research Group, Gene Center LMU, Ludwig-Maximilians University, Munich, Feodor-Lynen-Str. 25, 81377 Munich, Germany.
[9]
DOI
10.3390/cancers12092429
PMID
32867046
发布时间
2020-10-28
换一批
换一批
